532034 — Safal Herbs Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Safal Herbs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.7 | 3.4 | 1.01 | 0 | 6.21 |
Cost of Revenue | |||||
Gross Profit | -0.371 | 0.23 | 0.251 | 0 | 0.056 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 19.1 | 3.74 | 1.48 | 0.551 | 6.94 |
Operating Profit | -1.31 | -0.341 | -0.472 | -0.551 | -0.733 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.202 | -0.139 | -0.322 | 0.025 | 0.054 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.139 | -0.139 | -0.322 | 0.019 | 0.04 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.139 | -0.139 | -0.322 | 0.019 | 0.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.139 | -0.139 | -0.322 | 0.019 | 0.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | -0.001 | -0.003 | 0 | 0 |
Dividends per Share |